Quest Diagnostics Inc Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Quest Diagnostics Inc payments for repurchase of common stock for the quarter ending 2025-12-31 was $300.00M, a 98.68% increase year-over-year.
- Quest Diagnostics Inc payments for repurchase of common stock for the quarter ending 2025-09-30 was $150.00M.
- Quest Diagnostics Inc payments for repurchase of common stock for the quarter ending 2024-12-31 was $151.00M, a 45.09% decline year-over-year.
- Quest Diagnostics Inc payments for repurchase of common stock for the quarter ending 2023-12-31 was $275.00M, a 40.35% decline year-over-year.
- Quest Diagnostics Inc payments for repurchase of common stock for fiscal 2025 was $450.00M, a 198.01% increase from fiscal 2024.
- Quest Diagnostics Inc payments for repurchase of common stock for fiscal 2024 was $151.00M, a 45.09% decline from fiscal 2023.
- Quest Diagnostics Inc payments for repurchase of common stock for fiscal 2023 was $275.00M, a 80.47% decline from fiscal 2022.
- Quest Diagnostics Inc payments for repurchase of common stock for fiscal 2022 was $1.41B, a 35.97% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $300.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $450.00M 10-K · filed 2026-02-26 |
| 2025-09-30 | $150.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-21 | |
| 2024-12-31 | $151.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $151.00M 10-K · filed 2026-02-26 |
| 2023-12-31 | $275.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $275.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $461.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $835.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $0.00 10-Q · filed 2023-04-28 | $1.03B derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $461.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.41B 10-K · filed 2025-02-20 |
| 2022-09-30 | $374.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $1.24B derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $200.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $862.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $373.00M 10-Q · filed 2023-04-28 | $2.16B derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $289.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $2.20B 10-K · filed 2024-02-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | $2.16B derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $1.50B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $2.16B derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $410.00M 10-Q · filed 2022-04-22 | $660.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $250.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $325.00M 10-K · filed 2023-02-21 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $275.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-23 | $325.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $75.00M 10-Q · filed 2021-04-23 | $375.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $353.00M 10-K · filed 2022-02-28 |
| 2019-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $325.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $375.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $53.00M 10-Q · filed 2020-05-04 | $325.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $172.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $322.00M 10-K · filed 2021-02-22 |
| 2018-09-30 | $100.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $265.00M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $215.00M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-03-31 | $50.00M 10-Q · filed 2019-04-24 | $365.00M derived: sum of 4 quarters · filed 2020-02-20 |
| 2017-12-31 | $115.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $465.00M 10-K · filed 2020-02-20 |
| 2017-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-24 | $500.00M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | $150.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $500.00M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | $150.00M 10-Q · filed 2018-04-20 | $625.00M derived: sum of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | $150.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $590.00M 10-K · filed 2019-02-21 |
| 2016-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $490.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $275.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $465.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $115.00M 10-Q · filed 2017-04-21 | $229.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $224.00M 10-K · filed 2018-02-23 |
| 2015-09-30 | $25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-21 | $224.00M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | $39.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-25 | $224.00M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | $110.00M 10-Q · filed 2016-04-27 | $210.00M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $132.00M 10-K · filed 2017-02-22 |
| 2014-09-30 | $25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $125.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $582.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $32.00M 10-Q · filed 2015-04-30 | $1.01B derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $1.04B 10-K · filed 2016-02-26 |
| 2013-09-30 | $482.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $1.04B derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $450.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $612.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $62.00M 10-Q · filed 2014-05-01 | $212.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $200.00M 10-K · filed 2015-02-24 |
| 2012-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | $200.00M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $200.00M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $50.00M 10-Q · filed 2013-04-24 | $150.00M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $50.01M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $935.00M 10-K · filed 2014-02-18 |
| 2011-09-30 | $49.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $885.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $1.16B derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $835.00M 10-Q · filed 2012-04-27 | $1.33B derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $750.00M 10-K · filed 2013-02-27 |
| 2010-09-30 | $324.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $900.00M derived: sum of 4 quarters · filed 2012-02-16 |
| 2010-06-30 | $175.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | $675.76M derived: sum of 4 quarters · filed 2012-02-16 |
| 2010-03-31 | $250.71M 10-Q · filed 2011-05-10 | $500.70M derived: sum of 4 quarters · filed 2012-02-16 |
| 2009-12-31 | $150.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $499.99M 10-K · filed 2012-02-16 |
| 2009-09-30 | $99.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $603.99M derived: sum of 4 quarters · filed 2011-02-16 |
| 2009-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-27 | $504.00M derived: sum of 4 quarters · filed 2011-02-16 |
| 2009-03-31 | $250.00M 10-Q · filed 2010-04-26 | |
| 2008-12-31 | $254.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-16 | $254.00M 10-K · filed 2011-02-16 |
| 2008-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-27 | |
| 2007-12-31 | $145.66M 10-K · filed 2010-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |